Prevalence of viral hepatitis in Croatian adult population undergoing routine check-up, 2010-2011

Central European Journal of Public Health

Volumn 22, Issue 1, 2014, Pages 29-33

  Vilibić Čavlek, Tatjana ^a   Kučinar, Jasmina ^b   Ljubin Sternak, Sunčanica ^b   Kaić, Bernard ^c   Lazarić Stefanović, Lorena ^b   Kolarić, Branko ^d,e  

^a UNIVERSITY OF ZAGREB   (Croatia)

^b Istria County Institute of Public Health   (Croatia)

^c CROATIAN NATIONAL INSTITUTE OF PUBLIC HEALTH   (Croatia)

^d Zagreb Institute of Public Health   (Croatia)

^e UNIVERSITY OF RIJEKA   (Croatia)

Author keywords

Croatia; HAV; HBV; HCV; Seroprevalence

Indexed keywords

HEPATITIS A ANTIBODY; HEPATITIS B ANTIBODY; HEPATITIS C ANTIBODY;

ADULT; AGED; ARTICLE; BLOOD; CROATIA; DIAGNOSTIC TEST; EPIDEMIOLOGY; FEMALE; HEALTH; HUMAN; IMMUNOLOGY; MALE; METHODOLOGY; MIDDLE AGED; PHYSICAL EXAMINATION; PREVALENCE; STATISTICS; VERY ELDERLY; VIRUS HEPATITIS; YOUNG ADULT;

ADULT; AGED; AGED, 80 AND OVER; CROATIA; DIAGNOSTIC TESTS, ROUTINE; FEMALE; HEPATITIS A ANTIBODIES; HEPATITIS B ANTIBODIES; HEPATITIS C ANTIBODIES; HEPATITIS, VIRAL, HUMAN; HUMANS; MALE; MIDDLE AGED; PHYSICAL EXAMINATION; PREVALENCE; RURAL HEALTH; SEROEPIDEMIOLOGIC STUDIES; URBAN HEALTH; YOUNG ADULT;

EID: 84902182371     PISSN: 12107778     EISSN: None     Source Type: Journal    
DOI: 10.21101/cejph.a3844     Document Type: Article

References (37)

1. Hatzakis A, Wait S, Bruix J, Buti M, Carballo M, Cavaleri M, et al. The state of hepatitis B and C in Europe: report from the hepatitis B and C summit conference. J Viral Hepat. 2011 Sep;18 Suppl 1:1-16.
2. Daniels D, Grytdal S, Wasley A; Centers for Disease Control and Prevention (CDC). Surveillance for acute viral hepatitis-United States, 2007. MMWR Surveill Summ. 2009 May 22;58(3):1-27.
3. Bernard H, Frank C. Cluster of hepatitis A cases among travellers returning from Egypt, Germany, September through November 2008. Euro Surveill. 2009 Jan 22;14(3). pii: 19096.
4. Petrignani M, Harms M, Verhoef L, van Hunen R, Swaan C, van Steenbergen J, et al. Update: a food-borne outbreak of hepatitis A in the Netherlands related to semi-dried tomatoes in oil, January-February 2010. Euro Surveill. 2010 May 20;15(20). pii: 19572.
5. Gillesberg Lassen S, Soborg B, Midgley SE, Steens A, Vold L, Stene-Johansen K, et al. Ongoing multi-strain food-borne hepatitis A outbreak with frozen berries as suspected vehicle: four Nordic countries affected, October 2012 to April 2013. Euro Surveill. 2013 Apr 25;18(17):20467.
6. Mossong J, Putz L, Patiny S, Schneider F. Seroepidemiology of hepatitis A and hepatitis B virus in Luxembourg. Epidemiol Infect. 2006 Aug;134(4):808-13.
7. Chlíbek R, Čečetková B, Smetana J, Prymula R, Kohl I. Seroprevalence of antibodies against hepatitis A virus and hepatitis B virus in nonvaccinated adult population over 40 years of age. Epidemiol Mikrobiol Imunol. 2006 Aug;55(3):99-104. (In Czech.)
8. Quaglio G, Ramadani N, Pattaro C, Cami A, Dentico P, Volpe A, et al. Prevalence and risk factors for viral hepatitis in the Kosovarian population: implications for health policy. J Med Virol. 2008 May;80(5):833-40.
9. Vatev NT, Atanasova MV, Stoilova YD, Chervenyakova TP, Troyancheva MG. Seroprevalence of hepatitis A viral infection in Plovdiv, Bulgaria. Folia Med (Plovdiv). 2009 Jan-Mar;51(1):70-3.
10. Vilibic-Cavlek T, Kucinar J, Ljubin-Sternak S, Kolaric B. Seroepidemiology of hepatitis A in the Croatian population. Hepat Mon. 2011 Dec;11(12):997-9.
11. Fabris P, Baldo V, Baldovin T, Bellotto E, Rassu M, Trivello R, et al. Changing epidemiology of HCV and HBV infections in Northern Italy: a survey in the general population. J Clin Gastroenterol. 2008 May-Jun;42(5):527-32.
12. Baaten GG, Sonder GJ, Dukers NH, Coutinho RA, Van den Hoek JA. Population-based study on the seroprevalence of hepatitis A, B, and C virus infection in Amsterdam, 2004. J Med Virol. 2007 Dec;79(12):1802-10.
13. Meffre C, Le Strat Y, Delarocque-Astagneau E, Dubois F, Antona D, Lemasson JM, et al. Prevalence of hepatitis B and hepatitis C virus infections in France in 2004: social factors are important predictors after adjusting for known risk factors. J Med Virol. 2010 Apr;82(4):546-55.
14. Zacharakis G, Kotsiou S, Papoutselis M, Vafiadis N, Tzara F, Pouliou E, et al. Changes in the epidemiology of hepatitis B virus infection following the implementation of immunisation programmes in northeastern Greece. Euro Surveill. 2009 Aug 13;14(32). pii: 19297.
15. Cozzolongo R, Osella AR, Elba S, Petruzzi J, Buongiorno G, Giannuzzi V, et al.; NUTRIHEP Collaborating Group. Epidemiology of HCV infection in the general population: a survey in a southern Italian town. Am J Gastroenterol. 2009 Nov;104(11):2740-6.
16. Voiculescu M, Iliescu L, Ionescu C, Micu L, Ismail G, Zilisteanu D, et al. A cross-sectional epidemiological study of HBV, HCV, HDV and HEV prevalence in the SubCarpathian and South-Eastern regions of Romania. J Gastrointestin Liver Dis. 2010 Mar;19(1):43-8.
17. Gogos CA, Fouka KP, Nikiforidis G, Avgeridis K, Sakellaropoulos G, Bassaris H, et al. Prevalence of hepatitis B and C virus infection in the general population and selected groups in South-Western Greece. Eur J Epidemiol. 2003;18(6):551-7.
18. Nelson PK, Mathers BM, Cowie B, Hagan H, Des Jarlais D, Horyniak D, et al. Global epidemiology of hepatitis B and hepatitis C in people who inject drugs: results of systematic reviews. Lancet. 2011 Aug 13;378(9791):571-83.
19. Kolovrat A, Jurišić I, Marić Z, Cvitković A. Prevalence of hepatitis B, hepatitis C and HIV among injecting drug users treated outpatiently and in therapeutic community in Brod-Posavina County, Croatia. Acta Med Croatica. 2010 Oct;64(4):287-96. (In Croatian.)
20. Vilibić-Čavlek T, Marić J, Katičić L, Kolarić B. Hepatitis C virus antibody status, sociodemographic characteristics, and risk behaviour among injecting drug users in Croatia. Cent Eur J Public Health. 2011 Mar;19(1):26-9.
21. Bosevska G, Kuzmanovska G, Sikole A, Dzekova-Vidimilski P, Polenakovic M. Screening for hepatitis B, C and HIV infection among patients on haemodialysis (cross sectional analysis among patients from two dialysis units in the period January to July 2005). Prilozi. 2009 Dec;30(2):159-74.
22. Vilibic Cavlek T, Gjenero Margan I, Zidovec Lepej S, Kolaric B, Vince A. Seroprevalence, risk factors, and hepatitis C virus genotypes in groups with high-risk sexual behavior in Croatia. J Med Virol. 2009 Aug;81(8):1348-53.
23. Grgičević D, Balija M, Pirc-Tiljak D, Mihaljević I, Gjenero-Margan I, Zupančić-Šalek S, et al. Decreasing risk of viral transfusion-transmitted diseases in Croatia. Croat Med J. 2000 Jun;41(2):191-6.
24. Kolarić B, Štajduhar D, Gajnik D, Rukavina T, Wiessing L. Seroprevalence of blood-borne infections and population sizes estimates in a population of injecting drug users in Croatia. Cent Eur J Public Health. 2010 Jun;18(2):104-9.
25. Jelić O, Jelić D, Balen I, Jelić A, Jelić N, Mihaljević I. Prevalence of markers of hepatitis B virus infection among the general population of the municipality of Slavonski Brod. Acta Med Croatica. 1994;48(3):111-6.
26. Medić A, Dželalija B, Sonicki Z, Zekanović D. Characteristics of hepatitis C infection in injecting drug users in Zadar County, Croatia. Coll Antropol. 2008 Sep;32(3):697-702.
27. Bozicevic I, Dakovic Rode O, Zidovec Lepej S, Johnston LG, Stulhofer A, Dominkovic Z, et al. Prevalence of sexually transmitted infections among men who have sex with men in Zagreb, Croatia. AIDS Behav. 2009 Apr;13(2):303-9.
28. Burek V, Horvat J, Butorac K, Mikulić R. Viral hepatitis B, C and HIV infection in Croatian prisons. Epidemiol Infect. 2010 Nov;138(11):1610-20.
29. Vilibic-Cavlek T, Gjenero-Margan I, Retkovac B, Kolaric B, Bisko A, Banozic-Blagus Z, et al. Sociodemographic characteristics and risk behaviors for HIV, hepatitis B and hepatitis C virus infection among Croatian male prisoners. Int J Prison Health. 2011;7(1):28-31.
30. Domínguez A, Bruguera M, Plans P, Espuñes J, Costa J, Plasencia A, et al. Declining hepatitis A seroprevalence in adults in Catalonia (Spain): a population-based study. BMC Infect Dis. 2007 Jul 4;7:73.
31. Salleras L, Domínguez A, Bruguera M, Plans P, Costa J, Cardeñosa N, et al. Declining prevalence of hepatitis B virus infection in Catalonia (Spain) 12 years after the introduction of universal vaccination. Vaccine. 2007 Dec 17;25(52):8726-31.
32. Němeček V, Částková J, Fritz P, Linhartová A, Švandová E, Šrámová H, et al. The 2001 serological survey in the Czech Republic-viral hepatitis. Cent Eur J Public Health. 2003 Dec;11 Suppl:S54-61.
33. Eurohep. net. Surveillance of vaccine preventable hepatitis [Internet]. CEV/ESOC; c2002 [cited 2014 Feb 25]. Available from: http://www.eurohep.net/.
34. Gańczak M, Szych Z. Rationale against preoperative screening for HIV in Polish hospitals: a prevalence study of anti-HIV in contrast to anti-hepatitis C virus and hepatitis B surface antigen. Infect Control Hosp Epidemiol. 2009 Dec;30(12):1227-9.
35. Baklaić Ž, Dečković-Vukres V, Kuzman M, editors. Croatian health service yearbook 2010 [Internet]. Zagreb: Croatian National Institute of Public Health; 2011 [cited 2013 Jul 2]. Available from: http://hzjz.hr/wp-centent/uploads/2013/11/ljetopis_2011.pdf.
36. Ansaldi F, Bruzzone B, Salmaso S, Rota MC, Durando P, Gasparini R, et al. Different seroprevalence and molecular epidemiology patterns of hepatitis C virus infection in Italy. J Med Virol. 2005 Jul;76(3):327-32.
37. Gheorghe L, Csiki IE, Iacob S, Gheorghe C, Smira G, Regep L. The prevalence and risk factors of hepatitis C virus infection in adult population in Romania: a nationwide survey 2006-2008. J Gastrointestin Liver Dis. 2010 Dec;19(4):373-9.